Assessment of the safety, immunogenicity and efficacy of novel blood-stage malaria vaccines
Despite decades of research and the availability of effective medications, malaria remains a significant global health issue. The vast majority of infections are caused by two species: Plasmodium falciparum and Plasmodium vivax. There is currently no licensed malaria vaccine but an effective vaccine...
Main Author: | Payne, Ruth |
---|---|
Other Authors: | David, Dockrell |
Published: |
University of Sheffield
2016
|
Subjects: | |
Online Access: | https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.701460 |
Similar Items
-
The development of a blood-stage vectored vaccine against Plasmodium falciparum malaria
by: Goodman, Anna L.
Published: (2009) -
Analysis of immuno-epidemiological studies of blood stage malaria antigens
by: Bosomprah, Samuel
Published: (2012) -
HIV-1 Vaccine Immunogenicity Studies in Non-Human Primates
by: Rosario, Maximillian A.
Published: (2010) -
The development and the immunogenicity of an experimental chemically inactivated whole HIV-1 vaccine
by: Addawe, Mohamed Dayah
Published: (2000) -
Use of Schistosoma mansoni calreticulin, a highly immunogenic parasite antigen, in diagnosis of and vaccination against schistosomiasis
by: ElAswad, Bahaa El-Deen Wadea Ramadan
Published: (2010)